osteoarthritis

GSK pens $45M Relation-ship with AI biotech to identify fibrotic, osteoarthritis targets
Fierce Biotech
Tue, 12/10/24 - 10:44 am
GSK
Relation
artificial intelligence
osteoarthritis
fibrotic diseases
Ex-Pfizer drug reduces osteoarthritis pain in British biotech's phase 2 study
Fierce Biotech
Tue, 08/6/24 - 11:16 am
Pfizer
Levicept
osteoarthritis
LEVI-04
Novo Nordisk is concluding research on Wegovy’s impact on osteoarthritis
Stat
Thu, 11/2/23 - 11:35 am
Novo Nordisk
Wegovy
osteoarthritis
Ampio's years of troubles come to a head with internal investigation, trio of COVID trial failures
Fierce Biotech
Wed, 05/18/22 - 10:27 am
Ampio Pharmaceuticals
clinical trials
FDA
COVID-19
osteoarthritis
Eli Lilly and Pfizer Put Osteoarthritis Pain Drug Out of its Misery
BioSpace
Wed, 10/27/21 - 11:38 pm
Eli Lilly
Pfizer
tanezumab
osteoarthritis
A tiny biotech racks up another PhIII fail, crippling its share price
Endpoints
Mon, 08/30/21 - 10:53 am
Bone Therapeutics
clinical trials
osteoarthritis
JTA-004
FDA Advisory Committee Raises Objections to Pfizer and Eli Lilly’s Tanezumab
BioSpace
Thu, 03/25/21 - 10:47 pm
FDA
advisory panels
Pfizer
Eli Lilly
tanezumab
osteoarthritis
Pfizer has run 41 trials over 15 years for tanezumab. As adcomm nears, the FDA remains unimpressed — and more than a little worried
Endpoints
Mon, 03/22/21 - 10:42 am
Pfizer
Eli Lilly
tanezumab
FDA
advisory panels
osteoarthritis
Pfizer-Lilly Endeavor Shows NGF Inhibitor Tanezumab Lowers Osteoarthritic Pain
BioSpace
Thu, 10/8/20 - 11:29 pm
Pfizer
Eli Lilly
tanezumab
BLA
osteoarthritis
Occupied with immunology and cancer, Merck KGaA hands off osteoarthritis drug to Novartis for €50M cash
Endpoints
Tue, 10/6/20 - 11:26 pm
Merck
KGaA
Novartis
sprifermin
osteoarthritis
Novartis’ Ilaris unexpectedly slashes need for joint replacements from osteoarthritis in key study
Fierce Biotech
Mon, 08/3/20 - 11:45 pm
Novartis
Ilaris
osteoarthritis
joint replacements
Dogs help Eli Lilly scientists identify new osteoarthritis target
Fierce Biotech
Fri, 11/1/19 - 10:25 am
osteoarthritis
Eli Lilly
drug discovery
R&D
osteoarthritis in dogs
Looking to resolve lingering doubts, Gilead unleashes a $5B late-stage cash alliance with Galapagos
Endpoints
Sun, 07/14/19 - 04:01 pm
Gilead Sciences
Galapagos
IPF
osteoarthritis
Here's Why Unity Biotechnology Dropped as Much as 20.4% Today
Motley Fool
Tue, 06/18/19 - 11:27 pm
Unity Biotechnology
clinical trials
UBX0101
osteoarthritis
Pfizer and Lilly’s tanezumab succeeds in second phase 3 osteoarthritis pain trial
Pharmaceutical Business Review
Wed, 01/30/19 - 10:05 am
Pfizer
Eli Lilly
tanezumab
clinical trials
osteoarthritis pain
osteoarthritis
Pfizer-Lilly non-opioid drug helps reduce osteoarthritis pain
Yahoo/Reuters
Tue, 10/23/18 - 11:09 pm
Pfizer
Eli Lilly
osteoarthritis
opioid alternatives
painkillers
Teva and Regeneron's Fasinumab Meets Primary and Secondary Endpoints in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
CP Wire
Thu, 08/16/18 - 01:53 pm
Teva Pharmaceutical
Regeneron
fasinumab
osteoarthritis
Teva and Regeneron's Fasinumab Meets Primary and Secondary Endpoints in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
Thu, 08/16/18 - 09:58 am
Teva Pharmaceutical
Regeneron
fasinumab
osteoarthritis
Ampio Pharma craters on FDA setback but plans to fight back
Fierce Biotech
Thu, 08/9/18 - 10:03 pm
Ampio Pharmaceuticals
FDA
clinical trials
osteoarthritis
Ampion
Regeneron halts high doses of phase 3 osteoarthritis drug fasinumab amid risk-benefit concerns
Fierce Biotech
Fri, 05/4/18 - 10:05 am
Regeneron
fasinumab
clinical trials
osteoarthritis

Pages